Alpha-1-To-One is filled with practical advice, personal stories and news for people touched by Alpha-1 Antitrypsin Deficiency.
In the Spring 2016 issue:
- Mark Brantly, MD, talks about his career and hopes for new therapies. "I promised everybody that I was going to develop new therapies for this community. That is my mission in life."
- Perfusion systems continue to save lungs once considered not transplantable. Martin Zamora, MD, and Michael Weyant, MD, began working on the NOVEL trial of ex vivo lung perfusion system.
- Jim Keith talks about how pulmonary rehab changed his life and provided him with education and support for all aspects of living with Alpha-1 lung disease.